Kemény-Beke Á - Search Results

1

Increased production of asymmetric dimethylarginine (ADMA) in ankylosing spondylitis: association with other clinical and laboratory parameters.

Kemény-Beke Á, Gesztelyi R, Bodnár N, Zsuga J, Kerekes G, Zsuga M, Biri B, Kéki S, Szodoray P, Berta A, Szekanecz Z, Szántó S. Kemény-Beke Á, et al. Joint Bone Spine. 2011 Mar;78(2):184-7. doi: 10.1016/j.jbspin.2010.05.009. Joint Bone Spine. 2011. PMID: 20620092

2

Anti-mutated citrullinated vimentin (anti-MCV) and anti-65 kDa heat shock protein (anti-hsp65): new biomarkers in ankylosing spondylitis.

Bodnár N, Szekanecz Z, Prohászka Z, Kemény-Beke A, Némethné-Gyurcsik Z, Gulyás K, Lakos G, Sipka S, Szántó S. Bodnár N, et al. Joint Bone Spine. 2012 Jan;79(1):63-6. doi: 10.1016/j.jbspin.2011.03.010. Epub 2011 Jun 16. Joint Bone Spine. 2012. PMID: 21683641

3

Ocular manifestations of rheumatic diseases.

Kemeny-Beke A, Szodoray P. Kemeny-Beke A, et al. Int Ophthalmol. 2020 Feb;40(2):503-510. doi: 10.1007/s10792-019-01183-9. Epub 2019 Oct 3. Int Ophthalmol. 2020. PMID: 31583550 Review.

4

Safety and efficacy of etanercept therapy in ankylosing spondylitis patients undergoing phacoemulsification surgery.

Kemény-Beke A, Szekanecz Z, Szántó S, Bodnár N, Módis L Jr, Gesztelyi R, Zsuga J, Szodoray P, Berta A. Kemény-Beke A, et al. Rheumatology (Oxford). 2010 Nov;49(11):2220-1. doi: 10.1093/rheumatology/keq288. Epub 2010 Sep 9. Rheumatology (Oxford). 2010. PMID: 20833644 No abstract available.

5

The influence of affinity, efficacy, and slope factor on the estimates obtained by the receptorial responsiveness method (RRM): a computer simulation study.

Grenczer M, Pinter A, Zsuga J, Kemeny-Beke A, Juhasz B, Szodoray P, Tosaki A, Gesztelyi R. Grenczer M, et al. Can J Physiol Pharmacol. 2010 Nov;88(11):1061-73. doi: 10.1139/y10-078. Can J Physiol Pharmacol. 2010. PMID: 21076494

6

Association between objective signs and subjective symptoms of dry eye disease in patients with systemic sclerosis.

Rentka A, Nagy A, Harsfalvi J, Szucs G, Szekanecz Z, Gesztelyi R, Szodoray P, Kemeny-Beke A. Rentka A, et al. Rheumatol Int. 2017 Nov;37(11):1835-1845. doi: 10.1007/s00296-017-3794-2. Epub 2017 Sep 7. Rheumatol Int. 2017. PMID: 28884335

7

Corneal Manifestations of Systemic Sclerosis.

Nagy A, Rentka A, Nemeth G, Ziad H, Szücs G, Szekanecz Z, Gesztelyi R, Zsuga J, Aszalos Z, Szodoray P, Kemeny-Beke A. Nagy A, et al. Ocul Immunol Inflamm. 2019;27(6):968-977. doi: 10.1080/09273948.2018.1489556. Epub 2018 Jul 17. Ocul Immunol Inflamm. 2019. PMID: 30015530

8

A Wide Spectrum of Ocular Manifestations Signify Patients with Systemic Sclerosis.

Szucs G, Szekanecz Z, Aszalos Z, Gesztelyi R, Zsuga J, Szodoray P, Kemeny-Beke A. Szucs G, et al. Among authors: kemeny beke a. Ocul Immunol Inflamm. 2021 Jan 2;29(1):81-89. doi: 10.1080/09273948.2019.1657467. Epub 2019 Oct 2. Ocul Immunol Inflamm. 2021. PMID: 31577461

9

Adenosine deaminase inhibition enhances the inotropic response mediated by A1 adenosine receptor in hyperthyroid guinea pig atrium.

Kemeny-Beke A, Jakab A, Zsuga J, Vecsernyes M, Karsai D, Pasztor F, Grenczer M, Szentmiklosi AJ, Berta A, Gesztelyi R. Kemeny-Beke A, et al. Pharmacol Res. 2007 Aug;56(2):124-31. doi: 10.1016/j.phrs.2007.04.017. Epub 2007 May 10. Pharmacol Res. 2007. PMID: 17574432

10

Prior transient ischemic attack is independently associated with lesser in-hospital case fatality in acute stroke.

Zsuga J, Gesztelyi R, Juhasz B, Kemeny-Beke A, Fekete I, Csiba L, Bereczki D. Zsuga J, et al. Psychiatry Clin Neurosci. 2008 Dec;62(6):705-12. doi: 10.1111/j.1440-1819.2008.01874.x. Psychiatry Clin Neurosci. 2008. PMID: 19068008 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

46 results

Search Page

Filters